Efficacy and Safety of Alefacept in Combination With Narrow-band UVB (nbUVB) Compared to Alefacept Alone in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Phase of Trial: Phase IV
Latest Information Update: 04 Jun 2015
At a glance
- Drugs Alefacept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 08 Feb 2011 Results presented at the 69th Annual Meeting of the American Academy of Dermatology.
- 08 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Oct 2009 New trial record.